Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes

Mostafa Safi1, Anna Borup1, Christian Stevns Hansen2

  • 1Department of Clinical Biochemistry, Rigshospitalet, Denmark; Department of Biomedical Sciences, University of Copenhagen, Denmark.

Insights

Increased plasma apolipoprotein M (apoM) is linked to a higher risk of cardiac autonomic neuropathy (CAN) in individuals with Type 1 Diabetes. This finding suggests potential changes in the autonomic nervous system

Area of Science:

  • Cardiovascular Research
  • Metabolic Disorders
  • Autonomic Nervous System Function

Background:

  • Diabetes mellitus can lead to serious complications like cardiac autonomic neuropathy (CAN), increasing cardiovascular mortality risk.
  • Cardiac autonomic neuropathy (CAN) is diagnosed by reduced heart rate variability (HRV).
  • HDL-associated apolipoprotein M (apoM) influences heart rate and HRV, with S1P agonists showing potential therapeutic benefits.

Purpose of the Study:

  • To investigate the association between plasma levels of apolipoprotein M (apoM) and the risk of developing cardiac autonomic neuropathy (CAN).
  • To explore the relationship between apoM and heart rate variability (HRV) indices in individuals with Type 1 Diabetes.

Main Methods:

  • The study included 278 individuals diagnosed with Type 1 Diabetes.
  • Data was collected from participants recruited at Steno Diabetes Center in Copenhagen between 2010 and 2012.
  • Plasma apoM levels were measured and analyzed for association with CAN diagnosis and HRV parameters.

Main Results:

  • Elevated plasma apoM levels were significantly associated with an increased risk of CAN.
  • A 0.1 µM increase in plasma apoM correlated with CAN diagnosis (OR: 1.11, p=0.013).
  • Plasma apoM was also linked to reduced HRV indices, including SDNN and high-frequency power, even after adjusting for various clinical factors.

Conclusions:

  • Increased plasma apoM is associated with a higher risk of cardiac autonomic neuropathy (CAN) in Type 1 Diabetes patients.
  • The observed association suggests potential alterations in parasympathetic activity.
  • Further research is warranted to elucidate the underlying molecular mechanisms and explore additional contributing factors.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
70
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
719
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
38
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K